DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

OncoGenex's AFFINITY on Track, Passes Futility Analysis - Analyst Blog

Teva Pharmaceutical Industries (TEVA) Moving On Heavy Volume In The Pre-Market Hours

Generics Prices Spike: 2 Stock Choices - Analyst Blog

Week In Review: WuXi PharmaTech Pays $65 Million For Genomics Company

Impax Soars on FDA Nod of Parkinson's Disease Drug Rytary - Analyst Blog

Teva: New Generic Launches Will Benefit Earnings

Update: U.S. Launch Of Generic Diovan Improves Teva's Outlook

Does Pfizer Inc. Stock Offer a Market-Crushing Opportunity in 2015?

Pfizer's stock has languished for the better part of a decade now, failing to benefit from the broader bull market. With several key events on the horizon, this trend could change in a big way. Here's what investors need to know.

Does This Dividend Stock Belong in Your Portfolio in 2015?

Teva Pharmaceutical Industries is a favorite name among income investors. With steep headwinds facing the company in 2015, though, its dividend might be at risk. Here's what investors need to know.

Teva Pharmaceutical Industries: Is It Time To Buy Or Sell?